Vanguard Group’s Bolt Biotherapeutics BOLT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $341K | Sell |
58,484
-1,111,221
| -95% | -$6.48M | ﹤0.01% | 4000 |
|
|
2025
Q1 | $468K | Buy |
1,169,705
+102,300
| +10% | +$40.9K | ﹤0.01% | 3905 |
|
|
2024
Q4 | $571K | Hold |
1,067,405
| – | – | ﹤0.01% | 3914 |
|
|
2024
Q3 | $692K | Hold |
1,067,405
| – | – | ﹤0.01% | 3886 |
|
|
2024
Q2 | $801K | Buy |
1,067,405
+29,802
| +3% | +$22.4K | ﹤0.01% | 3866 |
|
|
2024
Q1 | $1.45M | Buy |
1,037,603
+106,474
| +11% | +$149K | ﹤0.01% | 3694 |
|
|
2023
Q4 | $1.04M | Buy |
931,129
+6,864
| +0.7% | +$7.69K | ﹤0.01% | 3817 |
|
|
2023
Q3 | $961K | Sell |
924,265
-4,011
| -0.4% | -$4.17K | ﹤0.01% | 3843 |
|
|
2023
Q2 | $1.19M | Hold |
928,276
| – | – | ﹤0.01% | 3850 |
|
|
2023
Q1 | $1.29M | Hold |
928,276
| – | – | ﹤0.01% | 3837 |
|
|
2022
Q4 | $1.21M | Sell |
928,276
-11,993
| -1% | -$15.6K | ﹤0.01% | 3849 |
|
|
2022
Q3 | $1.39M | Buy |
940,269
+50,477
| +6% | +$74.7K | ﹤0.01% | 3885 |
|
|
2022
Q2 | $1.82M | Buy |
889,792
+41,982
| +5% | +$85.6K | ﹤0.01% | 3845 |
|
|
2022
Q1 | $2.32M | Sell |
847,810
-150,337
| -15% | -$412K | ﹤0.01% | 3897 |
|
|
2021
Q4 | $4.89M | Buy |
998,147
+4,883
| +0.5% | +$23.9K | ﹤0.01% | 3622 |
|
|
2021
Q3 | $12.6M | Buy |
993,264
+346,194
| +54% | +$4.38M | ﹤0.01% | 3118 |
|
|
2021
Q2 | $10M | Sell |
647,070
-11,635
| -2% | -$180K | ﹤0.01% | 3200 |
|
|
2021
Q1 | $21.7M | Buy |
+658,705
| New | +$21.7M | ﹤0.01% | 2745 |
|